Korean J Med.
2006 Aug;71(2):124-131.
A new era of B cell lymphoma treatment by using monoclonal antibody: Rituximab (anti-CD20 antibody)
- Affiliations
-
- 1Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Hematopoietic Stem Cell Transplantation Center, St. Mary's Hospital, Seoul, Korea.
Abstract
- No abstract available.
Keyword
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effect of Anti-CD20 Monoclonal Antibody (Rituximab) on Recalcitrant Pemphigus Vulgaris
- A Case of Prolonged Hypogammaglobulinemia after Rituximab-Containing Chemotherapy in a Patient with Lymphoma
- Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy
- A Case of Successful Third Renal Transplantation Using Rituximab (anti-CD20 Monoclonal Antibody) in a Highly Sensitized Patient
- Treatment of indolent lymphoma
